- Blenrep Returns: ADC Combo Approved for R/R MM Medscape
- FDA delivers split decision on GSK’s blood cancer drug Blenrep, approving its use in some cases statnews.com
- Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD AJMC
- Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma Business Wire
- C Ola Landgren: FDA Approved GSK’s Drug, Blenrep Oncodaily